The KDM6A gene helps switch other genes on and off at the right time during early development. This gene plays an important role in guiding growth of the brain, face, heart, and other organs. If it does not work properly, a person may have Kabuki syndrome, which can affect learning, growth, muscle tone, feeding, hearing, and sometimes the heart. Because the KDM6A gene is on the X chromosome, effects can vary from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Others mostly direct when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
KDM6AGene function
What if the gene works
The KDM6A gene helps switch other genes on at the right time by changing how DNA is packaged. This supports normal development, cell growth, and the way tissues form.
Risk
What if the gene does not work
Variants in the KDM6A gene can cause Kabuki syndrome, with developmental and learning differences, low muscle tone, and growth or organ changes that range from mild to more marked. Acquired variants in body cells are also linked to some cancers.
Treatment
What does that mean for your treatment
No KDM6A-specific treatment or drug choice is currently established in clinical guidelines, so care is based on a person’s features and standard management of the condition. The KDM6A gene is also being studied in cancer and epigenetic research as a biomarker and possible drug target, but this has not led to routine treatment decisions for inherited KDM6A-related conditions.
Conditions associated with KDM6A
Gene function
What if the gene works
Many day to day cell tasks depend on timing. The KDM6A gene helps cells switch important genes on by adjusting chemical tags on the proteins that package DNA. Understanding what the KDM6A gene does in the body helps explain how cells guide growth, development, and normal cell activity.
The KDM6A gene helps remove small chemical marks from histones, the proteins that package DNA. This makes selected stretches of DNA easier for the cell to read and use.
Its protein helps keep some parts of DNA in a more open, usable state. That support allows cells to respond to everyday signals by turning needed genes on at the right time.
During growth and early development, this gene helps activate sets of genes in the right order. This orderly timing supports how tissues form and how cells take on their specific roles.
Many cells use the KDM6A gene to maintain stable patterns of gene activity over time. This helps a skin cell stay a skin cell, for example, instead of drifting from its usual job.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KDM6A gene can change the protein’s shape, stability, or ability to remove chemical tags from proteins that package DNA, which alters how other genes are switched on during development. This is part of how KDM6A gene variants affect cells: milder changes may leave some activity intact, while more severe variants can leave little or no working protein. This bigger functional loss is linked to Kabuki syndrome and may contribute to more noticeable features.
How variants are linked to conditions
Pathogenic variants in the KDM6A gene are a well-established cause of Kabuki syndrome, often described as KDM6A-related Kabuki syndrome. This genetic condition can include developmental delay, differences in learning, low muscle tone, short stature, and sometimes heart, kidney, hearing, or feeding concerns. The presentation varies from person to person, and both children and adults may be affected.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and are simply part of normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than confirming a diagnosis, especially when several genes and environmental factors also contribute. In some cases, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KDM6A, risk is mainly determined by whether a disease-causing gene change is present, either inherited or happening new in a child. Because KDM6A is on the X chromosome, sex and the exact gene change can affect how strongly features show. Lifestyle changes are not known to lower the chance of having a KDM6A-related condition.
Inheritance of KDM6A variants
KDM6A-related conditions are usually inherited in an X linked dominant pattern, which helps explain how KDM6A variants are inherited in families. If a mother carries a disease-causing variant in the KDM6A gene, each child has a 50% chance of inheriting it; if a father carries it, all daughters and none of his sons inherit the variant. Some people with a KDM6A variant are the first in their family to have it because the change began new in them rather than being passed down from a parent.
What does my KDM6A result mean for my family?
A change in the KDM6A gene is usually linked to an X-linked condition called Kabuki syndrome, so close relatives can sometimes have the same gene change and may have similar features, even if those features are mild. Parents, brothers, sisters, and children may want to learn whether the result could apply to them. Some KDM6A changes happen for the first time in one person, so a parent does not always carry it.
Genetic information
Genetic testing
How you find out about variants
KDM6A genetic testing usually uses a blood or saliva sample to read the KDM6A gene and look for variants, often through a multigene panel or exome sequencing. Results may show a pathogenic variant that helps confirm a diagnosis, or a variant of uncertain significance that needs careful interpretation.
When should I consider getting a genetic test?
Genetic testing for the KDM6A gene may be worth considering when someone has signs of Kabuki syndrome, such as delayed development, low muscle tone, feeding problems, short stature, or certain heart, kidney, or hearing problems. Testing can also help when this condition runs in the family or a child has several of these features together.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and on the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. For topics like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, so the same dose can lead to different levels in the body. This is common and can influence how well a treatment works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medications. It focuses on gene drug patterns to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a medication works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the KDM6A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so general medication questions are best discussed with your doctor. Researchers are studying whether changes in KDM6A may affect how some cancers respond to treatment, but this is not yet part of standard prescribing.
History
KDM6A first drew attention in the early 2000s, when researchers studying the X chromosome identified it as a gene that can remain active on both copies in many females. It was initially also known as UTX, a name still seen in older research papers. Building on this early work, scientists uncovered more about the gene as interest in epigenetics, the study of how genes are switched on and off, expanded. A major milestone came in 2012, when harmful variants in the KDM6A gene were recognized as a cause of Kabuki syndrome, a condition affecting development and learning. Since then, KDM6A has become an important part of research on inherited conditions and some cancers. Its history reflects how genetics and epigenetics grew together into modern medicine.